Back to AI Alyeska Investment Group, L.P.

JANXJANX
12 quarters

Position history for AIAlyeska Investment Group, L.P.'s holdings in JANUX THERAPEUTICS INC

Alyeska Investment Group, L.P. holds 1.6M shares of JANX (JANUX THERAPEUTICS INC), worth $25.3M as of 2026-Q2. The position was increased (+2.9% shares). JANX represents 0.1% of Alyeska Investment Group, L.P.'s portfolio.

Current Value

$25.3M

Current Shares

1.6M

Total Value Change

+$23.5M

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.6M
+2.9%
$25.3M0.1%$15.36
29
2026-Q1
Increased
1.6M
+23.1%
$22.3M0.1%$13.44
35
2025-Q4
Increased
1.3M
+206.3%
$18M0.1%$13.83
46
2025-Q3
Increased
424,845
+64.2%
$10.4M0.0%$23.70
40
2025-Q2
Decreased
258,678
-36.7%
$6M0.0%$23.15
0
2025-Q1
Increased
408,678
+18.5%
$11M0.0%$29.10
33
2024-Q4
Increased
344,916
+69.8%
$18.5M0.1%$52.50
42
2024-Q3
Increased
203,184
+1.9%
$9.2M0.0%$46.25
28
2024-Q2
Increased
199,384
+3.3%
$8.4M0.0%$41.89
28
2024-Q1
Decreased
193,046
-2.3%
$7.3M0.0%$37.65
0
2023-Q4
Increased
197,490
+12.8%
$2.1M0.0%$10.73
29
2023-Q3
New
175,000
-
$1.8M0.0%$10.08
36

Other major holders of JANX: RA CAPITAL MANAGEMENT, L.P., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used